Common Blood Pressure Drug May Increase Risk of Bleeding - News Center
Briefly

Genetic differences can impact how different people metabolize medications. This is particularly relevant when multiple medications used for the same condition, like atrial fibrillation, are impacted by these differences in metabolism...Our research group has looked at these differences and how they can cause negative effects.
Patients receiving diltiazem were 20 percent more likely to experience bleeding-related hospitalization and death...while there are some benefits to using diltiazem over metoprolol, differences in metabolism may introduce some increased risks of bleeding in those taking diltiazem.
Read at News Center
[
]
[
|
]